# A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo

> **NCT01771471** · PHASE2 · TERMINATED · sponsor: **ISTO Technologies, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **BIOLOGICAL:** NuQu
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01771471
- **Lead sponsor:** ISTO Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Change in clinical strategy
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01771471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01771471, "A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01771471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*